View in EDS

PIK-75 overcomes venetoclax resistance via blocking PI3K-AKT signaling and MCL-1 expression in mantle cell lymphoma.

Saved in:
Bibliographic Details
Title: PIK-75 overcomes venetoclax resistance via blocking PI3K-AKT signaling and MCL-1 expression in mantle cell lymphoma.
Authors: Huang S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA., Liu Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA., Chen Z; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA., Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA., Jiang VC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA.
Source: American journal of cancer research [Am J Cancer Res] 2022 Mar 15; Vol. 12 (3), pp. 1102-1115. Date of Electronic Publication: 2022 Mar 15 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: e-Century Pub. Corp Country of Publication: United States NLM ID: 101549944 Publication Model: eCollection Cited Medium: Print ISSN: 2156-6976 (Print) Linking ISSN: 21566976 NLM ISO Abbreviation: Am J Cancer Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2156-6976